Fem Adapt™

AOR08002

A natural solution for Menopausal Symptoms

  • Helps reduce hot flashes and night sweats while also promoting mood balance
  • Helps balance hormones, reducing the risk of post-menopausal diseases
  • Provides four of the most effective and research-backed phytoestrogen
Non-GMO
Vegan

$39.96 or subscribe and get 20% off

In stock

Choose a subscription plan:

Fem Adapt™ is AOR’s premium menopause formula that is especially useful for hot flashes. While many formulas on the market contain ingredients with minimal research in menopausal women, doses that are too low or unstandardized botanical extracts, Fem Adapt™ provides the most powerful, clinically studied, standardized phytoestrogens in research-backed doses. Fem Adapt™ contains flax lignans, soy isoflavones, black cohosh and a standardized hops extract, which collectively can reduce the severity and frequency of hot flashes and other menopausal concerns.

Discussion

Fem Adapt™ was formulated with the most effective natural ingredients that may support a healthy transition into menopause.*

Guarantees

AOR™ guarantees that all ingredients have been declared on the label. Made without peanuts, dairy, eggs, shellfish or any animal by-product.

Adult Dosage

Take 2 capsules daily, or as directed by a qualified health care practitioner. Take a few hours before or after taking other medications or natural health products.

Cautions

Consult your physician before use if you are pregnant, lactating, have a medical condition, or are taking any medication. Keep out of reach of children.

Source

Botanical extracts
Non-GMO soy

Main Applications
  • Menopause
  • PMS
  • Women’s Health
Disclaimer

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Serving Size: 2 Capsules
Amount Per Serving
% Daily Value
Flax extract (Linum usitatissimum L. 25-65:1)
168 mg
Soy Isoflavone extract
60 mg
Total isoflavones
18.2 – 27.4 mg AIE*
Genistein/Genistin
0.5 – 0.8 mg AIE*
Black Cohosh extract (15-20:1)
80 mg
LIFENOL®ǂ Hops extract (15-25:1)
120 mg

†Daily Value not established

*Aglycone Isoflavone Equivalents

Other ingredients: microcrystalline cellulose, maltodextrin, tricalcium phosphate, silicon dioxide, sodium stearyl fumarate, silica and hypromellose.

Contains: Soy

‡LIFENOL® is a registered trademark of Naturex, Inc.

Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986;25:791-7.

Adlercreutz H, Heikkinen R, Woods M, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982;2:1295-9.

Allais G, Bussone G, De Lorenzo C, Mana O, Benedetto C. Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. Neurol Sci. 2005 May;26 Suppl 2:s125-9.

Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, Van Breemen RB,Farnsworth NR, Bolton JL. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003 Sep 10;51(19):5661-70.

Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother. 2002 Aug;56(6):283-8.

Cheng, G., Wilczek, B., Warner, M., Gustafsson, J-A., Landgren, B-M. Isoflavone treatment for actue menopausal symptoms. Menopause Vol 13, No 3, 468-473.

Erkkola R, Vervarcke S, Vansteelandt S, Rompotti P, De Keukeleire D, Heyerick A. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts.Phytomedicine. 2010 May;17(6):389-96.

Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006 May 20;54(2):164-75.

Ferrante F, Fusco E, Calabresi P, Cupini LM (2004). Phytooestrogens in the prophylaxis of menstrual migraine. Clin Neuropharmacol 27:137–140

Kapiotis S, Hermann M, Held I, et al. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 1997;17:2868-74.

Marini, H., Minutoli, L., Polito, F., Bitto, A., Altavilla, D. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women. Ann Intern Med 2007: 146:839-847.

Messina, M., Wood, C. Soy Isoflavones, estrogen therapy, and breast cancer risk: Analysis and commentary. Nutrition Journal 2008, 7:17

Powell SL, Gödecke T, Nikolic D, Chen SN, Ahn S, Dietz B, Farnsworth NR, van Breemen RB, Lankin DC, Pauli GF, Bolton JL. In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent. J Agric Food Chem. 2008 Dec 24;56(24):11718-26.

Qiu SX, Dan C, Ding LS, Peng S, Chen SN, Farnsworth NR, Nolta J, Gross ML, Zhou P. A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chem Biol. 2007 Jul;14(7):860-9.

Wang C, Makela T, Hase T, et al. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 1994;50:205-12.

Williamson-Hughes, P., Flickinger, B., Messina, M., Empie, M. Isoflavone supplements containing predominately genistein reduce hot flash symptoms: a critical review of published studies. Menopause. Vol 13, No 5, 831-839.